Substance P (SP), acting through up-regulated neurokinin 1 (NK1) receptors expressed in the peripheral tissues of the involved limb, appears to be a key signaling molecule supporting the signs and symptoms of CRPS [8, 9]. The gene discussed is TAC1; the disease is complex regional pain syndrome.